Clinical Study Into the Cosmetic Results of Leukosan Adhesive

June 30, 2014 updated by: Dr. Stephanie Krause

Clinical Study Into the Cosmetic Results of Leukosan Adhesive vs. Transcutaneous Wound Suture With Laparoscopic Trocar Incision

This clinical study aims to assess whether the benefits of using Leukosan Adhesive on trocar incisions are greater or equivalent to those provided by the standard therapy of transcutaneous sutures.

In particular, it tests the long-term cosmetic result after 3 months, the safety and tolerance, as well as the practicality of treatment with Leuksan Adhesive.

An open, randomised, controlled, prospective, single location, clinical study of women of ages between 18 and 60 years within the time span of March 2013 and April 2013.

Study Overview

Detailed Description

The medical devices compared were EU (European Union) approved market-ready products with relevant designation according to the legal requirements for medical devices and according to Council guideline 93/42/EWG dated 14th July.

Leukosan Adhesive is a sterile, ultra high viscose adhesive for external skin closure. Due to the skin's moisture, this skin adhesive polymerizes within seconds into a flexible film firmly holding the edges of the wound together and protecting the wound itself.

Premilene DSMP 24, 3/8 needle, thread 3/0 denier was used a a comparison. This suture material was the standard suture material used in the study centre.

Study Type

Interventional

Enrollment (Actual)

77

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hamburg, Germany, 20357
        • Tagesklinik Altonaer Strasse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female between 18 and 60
  • Undergone laparoscopic operation with 2 mirror image trocar incisions
  • Willing to attend examination at clinic at 7-12 days and 10-14 weeks
  • Signed agreement by participant

Exclusion Criteria:

  • Length of laparoscopic operation more than 2 hours
  • Hospitalisation due to complications
  • Circumstances leading to difference in trocar incisions
  • Existing scar less than 3 cm from the operation point
  • Diabetic condition melitis HbA1c>9mg/d
  • Known allergy to tissue adhesive
  • Participation in another study within 30 days

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Leukosan Adhesive
Leukosan Adhesive applied to one wound (left or right)
Leukosan adhesive applied to one wound
Transcutaneous suture applied to one wound
Active Comparator: Transcutaneous suture
Transcutaneous suture applied to second wound (left or right)
Leukosan adhesive applied to one wound
Transcutaneous suture applied to one wound

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient's satisfaction with cosmetic appearance/result of the wound
Time Frame: 3 months post operation
The primary outcome was the satisfaction of the patients with the cosmetic result of the wound healing after 3 months. This was measured by a visual analogue scale. In order to validate this result, an additional known wound assessment instrument, an ordinal scaled index, was implemented and the assessment of independent assessors was called on.
3 months post operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of complication
Time Frame: 7-12 days post-operation
7-12 days post-operation patients were examined for complications in treatment such as wound dehiscence, maceration, redness, overheating and pain
7-12 days post-operation
Intensity of pain
Time Frame: 7-12 days post-operation
7-12 days post-operation patients were examined for intensity of pain
7-12 days post-operation
Investigator's assessment of cosmetic outcome
Time Frame: At 3 months post-operation
The Investigator examined patients to assess the cosmetic outcome.
At 3 months post-operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Olaf Buchweitz, Priv.Doz., Tagesklinik Altonaer Strasse

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2012

Primary Completion (Actual)

April 1, 2013

Study Completion (Actual)

July 1, 2013

Study Registration Dates

First Submitted

June 30, 2014

First Submitted That Met QC Criteria

June 30, 2014

First Posted (Estimate)

July 2, 2014

Study Record Updates

Last Update Posted (Estimate)

July 2, 2014

Last Update Submitted That Met QC Criteria

June 30, 2014

Last Verified

June 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BSNMedicalC09962
  • PV4003 (Other Identifier: Ethik Kommission der Aerztekammer Hamburg)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wound Healing Cosmetic Result

Clinical Trials on Leukosan Adhesive

3
Subscribe